Homogeneous detection of a target through nucleic acid ligand-ligand beacon interaction
AssigneeGilead Sciences, Inc.
InventorsSumedha Jayasena, Larry Gold
Life of this patent
Estimating the term…
Loading patent…
AssigneeGilead Sciences, Inc.
InventorsSumedha Jayasena, Larry Gold
Estimating the term…
A homogeneous assay that utilizes molecular beacons as the reporter and nucleic acid ligands as the sensor is described. This assay, called the ligand beacon assay, is for the detection of target molecules in a test mixture. The concept of the ligand beacon assay was tested using several proteins to which high affinity and specific nucleic acid ligands are available. The assay specifically detects the molecular target that binds the nucleic acid ligand with high affinity and specificity. The range of the assay is dictated by the concentration of the nucleic acid ligand/ligand beacon pair used in the assay. Target proteins were detected in buffer as well as in plasma, expanding its applicability to clinical use. This is a simple to use and fast assay format with the potential for automation for high throughput screening applications.
A method for detecting the presence or absence of a target molecule in a test mixture which may contain said target molecule comprising:
A method for detecting the binding of an antibody to a target molecule comprising:
Dependencies are inferred from the claim text.